Abstract:Inflammation plays a central role in the development and progression of diabetic nephropathy (DN). Researches on novel anti-inflammatory agents may offer new opportunities for the treatment of DN. We previously found a chalcone derivative L6H21 could inhibit LPS-induced cytokine release from macrophages. The aim of this study was to investigate whether L6H21 could ameliorate the high glucose-mediated inflammation in NRK-52E cells and attenuate the inflammation-mediated renal injury. According to the results, L6H21 showed a great inhibitory effect on the expression of pro-inflammatory cytokines, cell adhesion molecules, chemokines, and macrophage adhesion via down-regulation of NF-κB/MAPKs activity in high glucose-stimulated renal NRK-52E cells. Further, in vivo oral administration with L6H21 at a dosage of 20mg/kg/2days showed a decreased expression of pro-inflammatory cytokines, cell adhesion molecules, which subsequently contributed to the inhibition on renal macrophage infiltration, the reduction of serum creatinine and BUN levels, and the improvement on the fibrosis and pathological changes in the renal tissues of diabetic mice. These findings provided that chalcone derived L6H21 may be a promising anti-inflammatory agent and have the potential in the therapy of diabetic nephropathy, and importantly, MAPK/NF-κB signaling system may be a novel therapeutic target for human DN in the future.

Retro-dihydrochalcones from the resin of Daemonorops draco and their inhibitory activities against renal fibrosis

Dihydrochalcones and Homoisoflavanes from the Red Resin of Dracaena Cochinchinensis (chinese Dragon's Blood).

Homoisoflavonoid Derivatives from the Red Resin of Dracaena Cochinchinensis.

Eight New Flavonoids from the Fruits of Daemonorops Draco.

A novel chalcone derivative attenuates the diabetes-induced renal injury via inhibition of high glucose-mediated inflammatory response and macrophage infiltration.

Flavonoid oligomers from Chinese dragon’s blood, the red resins of Dracaena cochinchinensis

Five new biflavonoids with acetylcholinesterase inhibitory activity from Diphylleia sinensis

New Ethylated Derivatives of Sulfur- and Nitrogen-Containing Artifacts from Tenodera sinensis Egg Pod and Their Anti-Renal Fibrosis

Flavonoid Dimers from the Total Phenolic Extract of Chinese Dragon's Blood, the Red Resin of Dracaena Cochinchinensis.

Unusual acetylated flavonol glucuronides, oxyphyllvonides A-H with renoprotective activities from the fruits of Alpinae oxyphylla

Chalcones, flavonoids, and aristolactam alkaloids from Friesodielsia kingii and their biological activities

New Flavonoid Glycosides And Cyanogenic Glycosides From Dracocephalum Peregrinum

Trimeric chalchonoids from the total phenolic extract of Chinese dragon's blood (the red resin of Dracaena cochinchinensis)

Meroterpenoids with a large conjugated system from Ganoderma lucidum and their inhibitory activities against renal fibrosis

Synthesis and Evaluation of Chalcone Derivatives as Prospective Anti-Inflammatory Compounds

Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.

Novel Iridoid Derivatives Isolated from the Roots of Patrinia scabra with Potential Anti-Renal Fibrosis Activity In Vitro

Oxytrodiflavanone A and Oxytrochalcoflavanones A,B: New Biflavonoids from Oxytropis chiliophylla

Antifungal and wound healing promotive compounds from the resins of Dracaena cochinchinensis

Dauresorcinols A and B, Two Pairs of Merosesquiterpenoid Enantiomers with New Carbon Skeletons from Rhododendron Dauricum

Dihydrochalcones and Diterpenoids from Pteris Ensiformis and Their Bioactivities